Dapagliflozin in Active Lupus Nephritis

Abroad (travel likely)RecruitingPHASE4

Conditions

Lupus Nephritis (LN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (April M. Jorge, MD) · amjorge@mgh.harvard.edu · 617-643-9624
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Karen H. Costenbader, MD, MPH) · KCostenbader@bwh.harvard.edu · 617-732-6088

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE4

Banī Suwayf, Egypt

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE2

Nanjing, China

A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Membranous Nephropathy · Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Lupus Nephritis

Abroad (travel likely)RecruitingPHASE3

Orchard Park, United States · Vitória, Brazil